BridgeBio to Participate in March Investor Conferences
BridgeBio (Nasdaq: BBIO) announced that management will participate in three March 2026 healthcare investor conferences with scheduled fireside chats in Boston and Miami.
Rhea-AI Summary
BridgeBio (Nasdaq: BBIO) announced that management will participate in three March 2026 healthcare investor conferences with scheduled fireside chats in Boston and Miami.
Presentations include TD Cowen on March 2, 2026 at 3:50 pm ET, Leerink Partners on March 10, 2026 at 1:00 pm ET, and Barclays on March 11, 2026 at 12:30 pm ET. Live webcasts and 90-day replays will be available on the company website.
Details
News Market Reaction – BBIO
On Feb 23, the day this news came out, BBIO closed 0.34% below the previous close.
Data tracked by StockTitan Argus for the Feb 23 session.
Key Figures
- TD Cowen conference
- 46th Annual
- TD Cowen 46th Annual Healthcare Conference
- TD Cowen session time
- 3:50 pm EST
- Fireside chat on Monday, March 2 at 3:50 pm EST
- TD Cowen date
- March 2
- Fireside chat on Monday, March 2 at 3:50 pm EST
- Leerink session time
- 1:00 pm EDT
- Fireside chat on Tuesday, March 10 at 1:00 pm EDT
- Leerink date
- March 10
- Fireside chat on Tuesday, March 10 at 1:00 pm EDT
- Barclays conference
- 28th Annual
- Barclays 28th Annual Global Healthcare Conference
- Barclays date
- March 11
- Fireside chat on Wednesday, March 11 at 12:30 pm EDT
- Webcast replay window
- 90 days
- Replay of the webcasts will be available for 90 days
Historical Context
-
Equity inducement grants to 34 new employees under Nasdaq Rule 5635(c)(4).
-
Announced date and webcast details for Q4 and full-year 2025 results.
-
Positive Phase 3 PROPEL 3 results for oral infigratinib in achondroplasia.
-
Correction and replacement of prior inducement grant disclosure for new employees.
-
Inducement RSU awards for 12 new employees under 2019 Inducement Equity Plan.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PALO ALTO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will participate in the following healthcare investor conferences:
- TD Cowen 46th Annual Healthcare Conference, Boston, MA: Fireside Chat on Monday, March 2 at 3:50 pm EST
- Leerink Partners Global Healthcare Conference, Miami, FL: Fireside Chat on Tuesday, March 10 at 1:00 pm EDT
- Barclays 28th Annual Global Healthcare Conference, Miami FL: Fireside Chat on Wednesday, March 11 at 12:30 pm EDT
To access the live webcast of BridgeBio’s presentations, please visit the “Events and Presentations” page within the Investors section of the BridgeBio website at https://investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.
About BridgeBio Pharma, Inc.
BridgeBio exists to develop transformative medicines for genetic conditions. Millions of people worldwide living with genetic conditions lack treatment options, often because drug development for small patient populations can be commercially challenging. We aim to bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations. Our decentralized, hub-and-spoke model is designed for speed, precision, and scalability. Autonomous and empowered teams focus on individual conditions, while a central hub provides the clinical, regulatory, and commercial capabilities needed to bring innovation to market. For more information, visit bridgebio.com and follow us on LinkedIn, X, Facebook, Instagram, YouTube, and TikTok.
BridgeBio Media Contact:
Bubba Murarka, Executive Vice President, Corporate Development
contact@bridgebio.com
(650)-789-8220
BridgeBio Investor Contact:
Chinmay Shukla, Senior Vice President, Strategic Finance
ir@bridgebio.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.